Navigation Links
Flextronics Completes Acquisition of Avail

SINGAPORE, Jan. 28 /PRNewswire-FirstCall/ -- Flextronics (Nasdaq: FLEX) today announced that it has completed the previously announced acquisition of Avail Medical Products Inc., a privately-held, market leader in manufacturing disposable medical devices. As a division of the Flextronics Medical segment, Avail will continue to operate as a stand-alone business. Flextronics Medical segment is one of the fastest growing Flextronics segments focused on providing outsourced design, manufacturing and logistics services to the medical device and equipment marketplace, including consumer diagnostic devices, lab and life science equipment, imaging and patient monitoring equipment, hospital beds, and drug delivery devices. With the combination of continued strong organic growth and the acquisition of Avail, Flextronics Medical expects to generate $850-$950 million in revenue in the fiscal year ending March 31, 2009, which represents a year-over-year expected growth rate of 90%.

"The acquisition of Avail expands our existing global design and manufacturing capabilities creating a more robust and competitive offering that now includes a wide range of disposable medical devices such as catheters, wound management and drug delivery devices. The addition of Avail establishes Flextronics as a leading supplier and partner for the medical industry," said Dan Croteau, president, Flextronics Medical. "This is a highly strategic acquisition for Flextronics and I am pleased to welcome the talented Avail staff to our organization."

About Flextronics

Headquartered in Singapore (Singapore Reg. No. 199002645H), Flextronics is a leading Electronics Manufacturing Services (EMS) provider focused on delivering complete design, engineering and manufacturing services to automotive, computing, consumer digital, industrial, infrastructure, medical and mobile OEMs. With the acquisition of Solectron, pro forma fiscal year 2007 revenues from continuing operations are more than US$30.0 billion. Flextronics helps customers design, build, ship, and service electronics products through a network of facilities in 30 countries on four continents. This global presence provides design and engineering solutions that are combined with core electronics manufacturing and logistics services, and vertically integrated with components technologies, to optimize customer operations by lowering costs and reducing time to market. For more information, please visit

This press release contains forward-looking statements. These forward- looking statements include statements related to plans, projections and estimates regarding the acquisition, including future financial and operating results. These forward-looking statements are based on current assumptions and expectations and involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. These risks include that the revenues, cost savings, growth prospects and any other synergies expected from the acquisition may not be fully realized due to difficulties integrating the businesses, operations and product lines of Avail or may take longer to realize than expected. The forward-looking statements in this communication are based on current expectations and Flextronics assumes no obligation to update these forward- looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements.

SOURCE Flextronics
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Flextronics to Report Third Quarter Results
2. Flextronics Announces Change in Control Repurchase Offer for Solectrons 0.50% Senior Convertible Notes
3. Flextronics Announces Second Quarter Record Results
4. Flextronics Announces Redemption and Change of Control Repurchase Offer for Solectron 8.00% Senior Subordinated Notes and Planned Change of Control Repurchase Offer for Solectrons 0.50% Senior Convertible Notes
5. Flextronics Completes Acquisition of Solectron
6. Flextronics Shareholders and Solectron Stockholders Approve Acquisition
7. Symmetry Medical Completes Acquisition of DePuy Orthopaedic Instrument Facility
8. Cardiac Science Completes Deployment of AEDs With Los Angeles County Fire Department
9. Edwards Lifesciences Completes Sale of LifeStent Product Line to Bard
10. Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
11. Specialty Blades, Inc. Completes Acquisition of Popper and Sons, Inc.
Post Your Comments:
(Date:11/30/2015)... ... December 01, 2015 , ... ... Colon as a 2015-2016 inductee into its VIP Woman of the Year ... is the nation’s leading networking organization exclusively for professional women, boasting 850,000 members ...
(Date:11/30/2015)... ... December 01, 2015 , ... The National ... 2015-2016 inductee into its VIP Woman of the Year Circle. She is recognized ... networking organization exclusively for professional women, boasting 850,000 members and over 200 operating ...
(Date:11/30/2015)... ... December 01, 2015 , ... Live Very Well is ... insurance plans on . The multi-carrier insurance exchange platform offers individual ... allowing consumers to compare, quote and match plans to meet their needs. ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... Until now, ... criteria set forth in the MOMS (Management of Myelomeningocele Study) trial. One of these ... Control and Prevention), a BMI of 18.5 to 24.9 is considered normal, 25 - ...
(Date:11/30/2015)... ... 2015 , ... Stress, anxiety, illness, infection or even a need for eyeglasses ... Heather Spader, MD, a new pediatric neurosurgeon at Joe DiMaggio Children’s Hospital in Hollywood, ... tumors. , “Bad headaches that don’t go away, that don’t have any ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015   Royal Philips ... ScanWise Implant, the industry,s first MRI guided user interface ... scanning of patients with MR Conditional implants, such as ... the 2015 Radiological Society of North America Annual ... exams and supports diagnostic confidence of this growing patient ...
(Date:11/30/2015)... Nov. 30, 2015 Baxalta Incorporated ... leader dedicated to delivering transformative therapies to ... conditions, today announced the launch and first ... an extended circulating half-life recombinant factor VIII ... full-length ADVATE [Antihemophilic Factor (Recombinant)]. The treatment ...
(Date:11/30/2015)... PUNE, India , November 30, 2015 ... new market research report "Dental Lasers Market by Product (Soft ... Treatment, Periodontitis), End User (Hospitals, Clinics), and Geography - Global ... USD 224.7 Million by 2020, at a CAGR of 5.2% ... , Browse 140 market data Tables and 62 Figures spread ...
Breaking Medicine Technology: